Trend Results : "Prostate Cancer"


Blog Post Results (1-20 of 2663)

FILTER RESULTS

Personalized Cancer Treatment, Driven by a Blood Filter the Size of a Credit Card

We were wrong about cancer. Calling an illness “prostate cancer” or “breast cancer” doesn’t get to the core of the problem. That classification system—using organs and parts of bodies—is far too broad. Even categorizing cancers based...Show More Summary

Modified Citrus Pectin Enhances Radiation Therapy in Prostate Cancer Treatment

Scientists at Tel Aviv Medical Center, Israel, have found that oral modified citrus pectin (MCP) enhances the anti-cancer and anti-metastatic effects of radiation therapy in the treatment of androgen-independent (AI) aggressive prostate cancer cells. Results were presented today at the American Association for Cancer Research (AACR) Annual Meeting 2015.

Trial shows benefit of 'BRCA-targeting' drug in prostate cancer

Men with prostate cancer benefit from treatment with the pioneering drug olaparib -- the first cancer drug to target inherited mutations -- according to the results of a major trial.

Use of radiotherapy after prostate cancer surgery declining, despite evidence of benefit

Despite strong evidence and guidelines supporting its use, post-surgical radiation therapy for prostate cancer patients at risk of recurrence is declining in the United States. This study finds fewer than 10 percent of patients at risk of recurrence received postoperative radiotherapy within six months of surgery in the U.S.

A New Lease on Life for Prostate Tissue

What if a prostate cancer patient could learn which anti-cancer treatments would work best for him without having to swallow a single pill or endure a single intravenous line or injection? Research from Rutgers Cancer Institute of New...Show More Summary

Medical News Today: African-American men at greater risk of prostate cancer, study finds

Compared with non-Hispanic white men, obesity presented a higher prostate cancer risk and may be 'uniquely harmful' to African-American men, a new study finds.

Zinc deficiency linked to activation of Hedgehog signaling pathway

Zinc deficiency -- long associated with numerous diseases, e.g., autism, lung cancer, prostate cancer, and ovarian cancers -- can lead to activation of the Hedgehog signaling pathway, a biomolecular pathway that plays essential roles in developing organisms and in diseases, according to new research.

Obesity associated with prostate cancer risk in African-American men

Obesity was associated with an increased risk for prostate cancer in African American men and that risk grew by nearly four times as body-mass index (BMI) increased, according to a new study. African American men have the highest incidence...Show More Summary

Obesity Significantly Increases Prostate Cancer Risk in African-American Men

Obesity in black men substantially increases the risk of low- and high-grade prostate cancer, while obesity in white men moderately reduces the risk of low-grade cancer and only slightly increases the risk of high-grade cancer, according to the first large, prospective study to examine how race and obesity jointly affect prostate cancer risk.

After prostate cancer, start walking, experts say

Walking at an easy pace for about three hours every week may be just enough physical activity to help prostate cancer survivors reduce damaging side effects of their treatment, according to a new study. "Non-vigorous walking for three...Show More Summary

Cancer Vaccines May Prolong Patient Survival Rates

Therapeutic anti-cancer vaccines developed to treat metastatic disease such as advanced prostate cancer or melanoma rarely have a noticeable effect on the tumor but have been associated with a statistically significant increase in patient survival. Show More Summary

University Hospitals Geauga Medical Center Performs First-Ever Prostate Cancer Treatment with New Device

Radiation oncology doctors at University Hospitals Geauga Medical Center perform the first-ever prostate cancer treatment with the newly approved SpaceOAR, which is an injectable gel that creates a space between the prostate and the rectum to move the rectum away from radiation used in treatment.

Medical News Today: Potential new biomarker for aggressive prostate cancer identified

Scientists have discovered a new biomarker for prostate cancer that could help clinicians distinguish fast- and slow-growing tumors.

Low Temperature Plasmas for Prostate Cancer Therapy

A recent publication in the British Journal of Cancer describes the first ever preclinical use of low temperature plasmas (LTPs) on normal and healthy prostate cells. LTPs are created by the breakdown of a gas following the application of a high electric field across the gas. Show More Summary

Researchers find protein that may signal more aggressive prostate cancers

A biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer has been discovered by researchers. Worldwide, prostate cancer is the second-most common cancer in men. In the U.S., about 221,000 new cases of prostate cancer will be diagnosed in 2015, resulting in roughly 27,500 deaths.

U-M Researchers Find Protein That May Signal More Aggressive Prostate Cancers

University of Michigan researchers have discovered a biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer.

Study: Dogs Have a 93 Percent Accuracy Rate In Detecting Prostate and Bladder Cancer

It appears that we would all be better off if we just let our dogs sniff our rear ends. In Buckinghamshire, researchers have found that dogs have a 93% reliability rate when detecting bladder and prostate cancer. The research by by Dr Claire Guest and her colleagues has been published in Humanitas Clinical and Research […]

Medical News Today: New low-temperature plasma treatment for prostate cancer developed

Scientists have discovered a potential new treatment for prostate cancer that causes cells to die in a different way to other therapies.

Enzalutamide: Indication of major added benefit for over 75-year-olds

In comparison with watchful waiting, the new drug Enzalutamide can prolong survival in certain patients with prostate cancer and delay the occurrence of disease complications, a new study concludes.

Copyright © 2015 Regator, LLC